Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Four Partners



Unlock datapoints

Portfolio analytics


News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 3
Average round size
The average size of a deal this fund participated in
Portfolio companies 2
Rounds per year 0.21
Lead investments 0
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 2
Key employees Soon

Areas of investment

  • Energy
  • Energy Storage
  • Therapeutics
  • Biotechnology
  • Pharmaceutical

In 2008 was created Four Partners, which is appeared as Corporate Investor.

The fund is constantly included in less than 2 deals per year. Comparing to the other companies, this Four Partners performs on 38 percentage points more the average number of lead investments. The higher amount of exits for fund were in 2011. The average startup value when the investment from Four Partners is 10-50 millions dollars. The top activity for fund was in 2008. The usual things for fund are deals in the range of 10 - 50 millions dollars.

The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Four Partners, startups are often financed by Prima Industrie, Kitty Hawk Capital, Fuqua Ventures. The meaningful sponsors for the fund in investment in the same round are Prima Industrie, Ersel Asset Management, 360 Capital Partners. In the next rounds fund is usually obtained by Tullis Health Investors, Prima Industrie, Ersel Asset Management.

Among the most successful fund investment fields, there are Therapeutics, Pharmaceutical. Besides, a startup requires to be at the age of 11-15 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Synageva BioPharma.

Read more

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Arcturus Capital California, Pasadena, United States
Ascender -
Asymmetry Ventures California, San Francisco, United States
Cintrifuse Syndicate Fund -
Cinven England, London, United Kingdom
CMS Medical Venture Investment -
Council Ventures Nashville, Tennessee, United States
France Angels France, Ile-de-France, Paris
Green Bank Houston, Texas, United States
Greenoaks Capital California, San Francisco, United States
Incofin Investment Management Antwerp, Antwerpen, Belgium
Marstar Alternative Investments -
Moji Fengyun (Beijing) Software Technology Development Co. Beijing, Beijing, China
Rock Oak Capital Partners Illinois, Machesney Park, United States
Sunlands Online Education Group Beijing, Beijing, China
Synergie Finance Dorset, Gillingham, United Kingdom
UB Ventures Chiyoda, Japan
Ufida Happiness Capital Beijing, Beijing, China


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Four Partners?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 3
Average round size 14M
Rounds per year 0.21
Peak activity year 2014
Lead investments 0
Follow on index 0.33
Exits 2
Group Appearance index 1.00
Crunchbase icon

Content report

The following text will be sent to our editors: